Company / SG&A per Share
Inhibikase Therapeutics, Inc. SG&A per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.09
FY2024
5-year range
$0.26 / $1.47
FY2021-FY2024
Trend
-26.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.26 to $1.09 over the past 2 years.
Based on SEC 10-K filings.
1.09 in FY2024 with a 3-year CAGR of +61.0%.
Increased from $0.26 to $1.09 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +61.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, sg&a per share decreased 26.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.09 | -26.1% |
| FY2023 | $1.47 | +468.9% |
| FY2022 | $0.26 | -0.9% |
| FY2021 | $0.26 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026